Nifedipine in medically refractory angina pectoris

Area of Science:

• Cardiology
• Pharmacology

Background:

• Angina pectoris management often requires advanced therapies.
• Refractory cases pose a clinical challenge.
• Coronary artery spasm is a known cause, but not always present.

Purpose of the Study:

• To evaluate nifedipine's efficacy in angina pectoris.
• To assess its effectiveness in patients unresponsive to standard treatments.
• To determine if nifedipine is beneficial without confirmed coronary spasm.

Main Methods:

• Administered nifedipine to 21 patients with refractory angina pectoris.
• Monitored patient condition and response.
• Recorded side effects, particularly nitrate-type.
• Concurrent medication included isosorbide dinitrate in some cases.

Main Results:

• Nifedipine improved the condition of 13 patients (62%).
• Eight patients (38%) experienced a long-term positive response.
• Seven patients (33%) reported nitrate-type side effects, often with concurrent isosorbide dinitrate.

Conclusions:

• Nifedipine is a promising therapeutic option for angina pectoris.
• Its benefits extend to patients without documented coronary artery spasm.
• Careful monitoring for side effects is advised, especially with combined nitrate therapy.